Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients-Reference-Cited by-同舟云学术

Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients

Published:2020-07-25 Issue:9 Volume:34 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Chen Xuduan¹^ORCID,Luo Xiaofeng²,Zu Yanping³,Issa Hajji Ally²,Li Linlin¹,Ye Hong¹,Yang Ting²,Hu Jianda²,Wei Lixin¹

Affiliation:

1. Department of Nephrology Fujian Medical University Union Hospital Fuzhou China

2. Fujian Institute of Hematology Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital Fuzhou China

3. Department of Nephrology Fujian Provincial Hospital Jinshan Branch Fuzhou China

Funder

Natural Science Foundation of Fujian Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23416

Reference32 articles.

1. Multiple myeloma

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

3. Managing renal complications in multiple myeloma

4. Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group

5. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous stem cell transplantation in newly diagnosed multiple myeloma patients with severe renal failure requiring hemodialysis. A single-center experience;Oncohematology;2024-09-02

2. Current progress in CAR-based therapy for kidney disease;Frontiers in Immunology;2024-08-20

3. The Role of Monoclonal Antibodies in the Treatment of Myeloma Kidney Disease;Pharmaceuticals;2024-08-05

4. Clinical and economic burden of medicare beneficiaries with multiple myeloma and renal impairment: An observational study;Medicine;2024-06-28

5. Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery;2024-04-16